Korro Bio, Inc.

KRRO

Korro Bio, Inc.

KRRO

Insider Sentiment (TTM):

Last Purchase:2026-03-31Last Sale:2026-06-24Shares Purchased (TTM):1,864,420Shares Sold (TTM):83,028

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:12,552,266Shares Outstanding:11,598,717Institutional Ownership Pct.:108.22%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	25	62	22	24	34	64	56	63	91	139	166	42
Available For Sale Securities Debt Securities Curr…	-	-	-	-	-	-	-	-	-	-	-	0
Marketable Securities Current	90	52	53	68	63	51	70	74	66	-	0	-
Assets Current
Assets Current	121	120	82	98	103	121	132	153	164	146	173	43
Short Term Investments	-	-	-	-	-	-	-	-	-	-	0	-
Accounts And Other Receivables Net Current	0	0	1	1	1	2	2	10	-	-	0	-
Prepaid Expense And Other Assets Current	6	6	6	5	5	4	4	4	4	3	3	0
Restricted Cash Current	-	-	1	-	-	0	0	2	2	4	4	-
Property Plant And Equipment Net	7	8	8	24	25	27	28	29	25	21	16	1
Operating Lease Right Of Use Asset	8	8	8	23	24	24	24	24	25	26	27	1
Restricted Cash Noncurrent	-	-	-	-	-	-	-	-	-	-	-	2
Restricted Cash Equivalents Noncurrent	2	2	2	2	2	3	3	3	3	3	3	-
Marketable Securities Noncurrent	23	43	10	10	23	24	37	32	30	-	0	-
Other Assets Noncurrent	2	2	2	3	3	3	3	2	3	2	3	-
Assets	163	184	114	162	180	202	226	244	250	198	222	46
Liabilities And Stockhold…
Liabilities
Accounts Payable Current	4	2	2	2	5	4	4	6	6	5	7	0
Accrued Liabilities Current	5	10	8	6	6	4	6	5	6	5	10	8
Liabilities Current
Liabilities Current	13	15	12	15	17	13	15	14	12	11	19	10
Operating Lease Liability Current	3	3	3	3	2	2	1	0	0	1	2	1
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	0
Deferred Revenue Current	1	0	0	3	4	3	4	2	-	-	0	-
Operating Lease Liability Noncurrent	39	40	41	42	42	43	43	42	38	35	31	0
Long Term Loans From Bank	-	-	-	-	-	-	-	-	-	-	-	0
Deferred Revenue Noncurrent	7	8	8	5	5	6	6	8	-	-	0	-
Other Liabilities Noncurrent	2	1	1	2	1	1	1	1	1	1	1	0
Liabilities	60	64	62	63	65	63	66	64	52	47	52	10
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Additional Paid In Capital	526	523	435	433	431	429	427	424	422	354	353	340
Stockholders Equity	103	120	51	99	115	139	160	180	198	151	170	-153
Accumulated Other Comprehensive Income Loss Net Of…	-0	0	0	0	0	0	0	1	0	-	0	0
Retained Earnings Accumulated Deficit	-422	-403	-384	-334	-316	-290	-267	-245	-224	-203	-183	-304
Liabilities And Stockholders Equity	163	184	114	162	180	202	226	244	250	198	222	46
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	15	14	9	9	9	9	9	9	9	8	8	37
Shares Outstanding	15	14	9	9	9	9	9	9	9	8	8	37

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	4.03%	-1.47%	-17.46%	-	-	-	-	-	-	-	-	-
2025	-18.02%	-13.64%	14.93%	107.50%	189.06%	155.85%	-77.66%	-74.38%	-57.57%	21.74%	18.00%	16.61%
2024	-7.29%	-27.01%	-16.38%	12.21%	-7.62%	59.96%	-34.63%	-34.23%	-47.62%	-46.63%	-35.62%	-39.64%
2023	-	-	-	-31.87%	-45.91%	-66.08%	170.46%	256.96%	190.46%	-23.24%	-37.14%	-52.16%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	9.55	8.13	6.90	6.71	5.98	9.41	8.79	11.23	13.28	13.18	8.87	4.42
Quick Ratio	9.11	7.71	6.38	6.37	5.67	9.07	8.54	10.93	12.92	12.88	8.71	4.38
Working Capital	108.00M	105.38M	70.44M	83.59M	85.46M	108.35M	116.57M	139.17M	151.30M	134.60M	153.25M	32.89M
Leverage & Debt
Debt to Equity	0.58	0.53	1.21	0.63	0.57	0.46	0.41	0.36	0.26	0.31	0.30	-0.06
Interest Coverage TTM	-	-	-	-	-	-	-	-447.49	-410.84	-257.19	-136.79	-72.39
Debt Ratio	0.37	0.35	0.55	0.39	0.36	0.31	0.29	0.26	0.21	0.24	0.23	0.21
Efficiency & Turnover
Asset Turnover TTM	0.01	0.02	0.04	0.04	0.03	0.02	0.01	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-6.05	-9.79	-12.48	-9.41	-9.73	-9.31	-9.37	-9.44	-9.49	-10.12	-53.08	-174.41
Free Cash Flow Per Share TTM	-4.36	-6.09	-8.42	-4.86	-5.25	-8.00	-8.74	-9.87	-9.22	-10.15	-49.12	-241.14
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-4,625.48%	-3,052.34%	-1,906.37%	-1,282.04%	-1,569.08%	-1,980.44%	-4,047.12%	-	-	-	-	-
Net Profit Margin TTM	-4,477.08%	-2,954.14%	-1,834.48%	-1,199.53%	-1,454.47%	-1,813.13%	-3,680.36%	-	-	-	-	-
Growth Metrics
Net Revenue Growth (1Y)	-62.08%	-20.31%	181.46%	-	-	-	-	-	-	-	-	-
Net Income Growth (1Y)	16.74%	29.84%	40.30%	0.69%	7.10%	7.75%	2.97%	77.18%	68.53%	49.53%	39.87%	-42.18%
EPS Growth (1Y)	-37.78%	5.05%	33.20%	-0.25%	2.49%	-7.92%	-82.35%	-94.59%	-94.81%	-94.94%	-76.66%	7,071.88%
Valuation Metrics
P/E TTM	-2.18	-1.16	-0.64	-5.09	-1.28	-1.87	-4.06	-3.54	-3.57	-8.90	-0.90	-0.11
P/B TTM	2.25	1.10	1.46	4.54	1.02	1.18	2.12	1.73	1.54	4.77	0.43	-0.03
P/S TTM	97.49	34.17	11.77	61.02	18.67	33.89	149.54	-	-	-	-	-
Market Cap	232.21M	131.30M	75.26M	449.76M	117.29M	163.38M	339.61M	310.91M	304.37M	721.77M	73.30M	5.26M
Enterprise Value	207.31M	69.60M	53.43M	425.61M	83.68M	99.24M	283.96M	247.71M	213.22M	582.96M	-92.85M	-36.47M
Calculated Values
Free Cash Flow TTM	-76.74M	-70.60M	-79.08M	-45.67M	-49.29M	-75.05M	-77.98M	-91.79M	-82.84M	-81.42M	-75.12M	-68.52M
Net Debt	-24.91M	-61.70M	-21.82M	-24.16M	-33.61M	-64.14M	-55.64M	-63.21M	-91.15M	-138.80M	-166.15M	-41.72M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-24Sale

Owner: Formela, Jean Francois

Title: -

Shares: 48,438

Price/Share: $14.79

Value: $716,398.02

Shares Owned: 169,556

Relationship: Director

Ownership: Indirect

2026-06-16Sale

Owner: Cerio, Jeffrey

Title: General Counsel

Shares: 6,609

Price/Share: $10.83

Value: $71,575.47

Shares Owned: 35,293

Relationship: Officer

Ownership: Direct

2026-06-16Sale

Owner: Dolan, Oliver

Title: Senior Vice President, Finance

Shares: 3,383

Price/Share: $10.83

Value: $36,637.89

Shares Owned: 18,099

Relationship: Officer

Ownership: Direct

2026-06-16Sale

Owner: Vincent, Loic A

Title: Chief Scientific Officer

Shares: 3,418

Price/Share: $10.83

Value: $37,016.94

Shares Owned: 18,297

Relationship: Officer

Ownership: Direct

2026-06-16Sale

Owner: Chappell, Todd

Title: Chief Operating Officer

Shares: 3,168

Price/Share: $10.83

Value: $34,309.44

Shares Owned: 16,964

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-24	Formela, Jean Francois	Director	-	Indirect	Sale	48,438	14.79	$716,398.02	169,556	4
2026-06-16	Cerio, Jeffrey	Officer	General Counsel	Direct	Sale	6,609	10.83	$71,575.47	35,293	4
2026-06-16	Dolan, Oliver	Officer	Senior Vice President, Finance	Direct	Sale	3,383	10.83	$36,637.89	18,099	4
2026-06-16	Vincent, Loic A	Officer	Chief Scientific Officer	Direct	Sale	3,418	10.83	$37,016.94	18,297	4
2026-06-16	Chappell, Todd	Officer	Chief Operating Officer	Direct	Sale	3,168	10.83	$34,309.44	16,964	4
2026-05-29	Aiyar, Ram	Director,Officer	President and CEO	Direct	Sale	15,152	12.98	$196,672.96	74,848	4
2026-05-28	Formela, Jean Francois	Director	-	Indirect	Sale	2,860	13.95	$39,897.00	194,655	4
2026-03-31	Nichols, Weston, Lynx1 Ca…	TenPercentOwner	-	Indirect	Purchase	520	10.60	$5,512.00	1,538,296	4
2026-03-10	Baskett, Forest	TenPercentOwner	-	Indirect	Purchase	207,100	11.11	$2,300,881.00	1,297,893	4
2026-03-10	Walker, Paul Edward	TenPercentOwner	-	Indirect	Purchase	207,100	11.11	$2,300,881.00	1,297,893	4
2026-03-10	Yang, Rick	TenPercentOwner	-	Indirect	Purchase	207,100	11.11	$2,300,881.00	1,297,893	4
2026-03-10	Florence, Anthony A. Jr.	TenPercentOwner	-	Indirect	Purchase	207,100	11.11	$2,300,881.00	1,297,893	4
2026-03-10	New, Enterprise Associate…	TenPercentOwner	-	Direct	Purchase	207,100	11.11	$2,300,881.00	1,297,893	4
2026-03-10	Mathers, Edward T	TenPercentOwner	-	Indirect	Purchase	207,100	11.11	$2,300,881.00	1,297,893	4
2026-03-10	Makhzoumi, Mohamad	TenPercentOwner	-	Indirect	Purchase	207,100	11.11	$2,300,881.00	1,297,893	4
2026-03-10	Sandell, Scott D	TenPercentOwner	-	Indirect	Purchase	207,100	11.11	$2,300,881.00	1,297,893	4
2026-03-10	Chang, Carmen	TenPercentOwner	-	Indirect	Purchase	207,100	11.11	$2,300,881.00	1,297,893	4
2024-11-11	Agarwal, Vineet	Officer	Chief Financial Officer	Direct	Sale	800	70.00	$56,000.00	0	4
2024-10-17	Agarwal, Vineet	Officer	Chief Financial Officer	Direct	Sale	10,216	77.60	$792,761.60	0	4
2024-04-22	Atlas, Venture Associates…	TenPercentOwner	-	Direct	Purchase	17,857	56.00	$999,992.00	195,074	4
2024-04-22	Walker, Paul Edward	TenPercentOwner	-	Indirect	Purchase	17,857	56.00	$999,992.00	1,090,793	4
2024-04-22	Mathers, Edward T	TenPercentOwner	-	Indirect	Purchase	17,857	56.00	$999,992.00	1,090,793	4
2024-04-22	Sandell, Scott D	TenPercentOwner	-	Indirect	Purchase	17,857	56.00	$999,992.00	1,090,793	4
2024-04-22	Nea, Partners 17, L.P., N…	TenPercentOwner	-	Direct	Purchase	17,857	56.00	$999,992.00	1,090,793	4
2024-04-22	Florence, Anthony A. Jr.	TenPercentOwner	-	Indirect	Purchase	17,857	56.00	$999,992.00	1,090,793	4
2024-04-22	Makhzoumi, Mohamad	TenPercentOwner	-	Indirect	Purchase	17,857	56.00	$999,992.00	1,090,793	4
2024-04-22	Chang, Carmen	TenPercentOwner	-	Indirect	Purchase	17,857	56.00	$999,992.00	1,090,793	4
2024-04-22	Yang, Rick	TenPercentOwner	-	Indirect	Purchase	17,857	56.00	$999,992.00	1,090,793	4
2024-04-22	Baskett, Forest	TenPercentOwner	-	Indirect	Purchase	17,857	56.00	$999,992.00	1,090,793	4
2023-11-22	Lucchino, David L.	Director	-	Direct	Sale	1,156	37.38	$43,211.28	22,150	4
2023-11-10	Lucchino, David L.	Director	-	Direct	Sale	968	42.63	$41,265.84	23,306	4
2023-08-21	Mitrano, Richard J.	Officer	VP Finance & Operations	Direct	Sale	237	0.53	$125.61	48,457	4
2023-08-21	Lucchino, David L.	Director,Officer	President and CEO	Direct	Sale	3,057	0.50	$1,528.50	633,744	4
2023-08-17	Lucchino, David L.	Director,Officer	President and CEO	Direct	Sale	2,733	0.63	$1,721.79	639,666	4
2023-08-17	Mitrano, Richard J.	Officer	VP Finance & Operations	Direct	Sale	230	0.62	$142.60	48,921	4
2023-08-15	Lucchino, David L.	Director,Officer	President and CEO	Direct	Sale	2,629	0.67	$1,761.43	645,294	4
2023-08-15	Mitrano, Richard J.	Officer	VP Finance & Operations	Direct	Sale	228	0.65	$148.20	49,385	4
2023-08-11	Mitrano, Richard J.	Officer	VP Finance & Operations	Direct	Sale	240	0.64	$153.60	49,851	4
2023-08-11	Lucchino, David L.	Director,Officer	President and CEO	Direct	Sale	2,733	0.67	$1,831.11	650,804	4
2023-08-09	Lucchino, David L.	Director,Officer	President and CEO	Direct	Sale	2,798	0.67	$1,874.66	656,327	4
2023-08-09	Mitrano, Richard J.	Officer	VP Finance & Operations	Direct	Sale	238	0.66	$157.08	50,338	4
2023-08-07	Lucchino, David L.	Director,Officer	President and CEO	Direct	Sale	2,857	0.68	$1,942.76	661,935	4
2023-08-07	Mitrano, Richard J.	Officer	VP Finance & Operations	Direct	Sale	235	0.69	$162.15	50,817	4
2023-08-03	Mitrano, Richard J.	Officer	VP Finance & Operations	Direct	Sale	232	0.56	$129.92	51,272	4
2023-08-03	Lucchino, David L.	Director,Officer	President and CEO	Direct	Sale	2,679	0.59	$1,580.61	667,342	4
2023-08-01	Lucchino, David L.	Director,Officer	President and CEO	Direct	Sale	2,799	0.49	$1,371.51	672,608	4
2023-08-01	Mitrano, Richard J.	Officer	VP Finance & Operations	Direct	Sale	238	0.48	$114.24	51,735	4
2023-07-28	Lucchino, David L.	Director,Officer	President and CEO	Direct	Sale	2,647	0.47	$1,244.09	678,083	4
2023-07-28	Mitrano, Richard J.	Officer	VP Finance & Operations	Direct	Sale	223	0.47	$104.81	52,195	4
2023-07-28	Loose, Christopher R.	Officer	Chief Scientific Officer	Direct	Sale	1,344	0.46	$618.24	183,650	4
2023-07-26	Mitrano, Richard J.	Officer	VP Finance & Operations	Direct	Sale	222	0.53	$117.66	52,645	4
2023-07-26	Loose, Christopher R.	Officer	Chief Scientific Officer	Direct	Sale	1,329	0.51	$677.79	186,367	4
2023-07-26	Lucchino, David L.	Director,Officer	President and CEO	Direct	Sale	2,609	0.52	$1,356.68	683,521	4
2023-07-24	Loose, Christopher R.	Officer	Chief Scientific Officer	Direct	Sale	1,438	0.54	$776.52	189,086	4
2023-07-24	Lucchino, David L.	Director,Officer	President and CEO	Direct	Sale	2,887	0.54	$1,558.98	688,933	4
2023-07-24	Mitrano, Richard J.	Officer	VP Finance & Operations	Direct	Sale	234	0.56	$131.04	53,101	4
2023-07-20	Loose, Christopher R.	Officer	Chief Scientific Officer	Direct	Sale	1,361	0.64	$871.04	191,857	4
2023-07-20	Lucchino, David L.	Director,Officer	President and CEO	Direct	Sale	2,710	0.64	$1,734.40	694,483	4
2023-07-20	Mitrano, Richard J.	Officer	VP Finance & Operations	Direct	Sale	229	0.64	$146.56	53,558	4
2023-07-18	Lucchino, David L.	Director,Officer	President and CEO	Direct	Sale	2,968	0.56	$1,662.08	699,839	4
2023-07-18	Loose, Christopher R.	Officer	Chief Scientific Officer	Direct	Sale	1,484	0.56	$831.04	194,553	4
2023-07-18	Mitrano, Richard J.	Officer	VP Finance & Operations	Direct	Sale	249	0.56	$139.44	54,015	4
2023-07-14	Mitrano, Richard J.	Officer	VP Finance & Operations	Direct	Sale	148	0.60	$88.80	54,508	4
2023-07-14	Lucchino, David L.	Director,Officer	President and CEO	Direct	Sale	1,815	0.59	$1,070.85	705,582	4
2023-07-14	Loose, Christopher R.	Officer	Chief Scientific Officer	Direct	Sale	906	0.59	$534.54	197,452	4
2023-07-12	Lucchino, David L.	Director,Officer	President and CEO	Direct	Sale	2,649	0.39	$1,033.11	710,043	4
2023-07-12	Mitrano, Richard J.	Officer	VP Finance & Operations	Direct	Sale	220	0.40	$88.00	54,883	4
2023-07-12	Loose, Christopher R.	Officer	Chief Scientific Officer	Direct	Sale	1,335	0.39	$520.65	199,687	4
2023-07-10	Mitrano, Richard J.	Officer	VP Finance & Operations	Direct	Sale	220	0.37	$81.40	55,331	4/A
2023-07-10	Loose, Christopher R.	Officer	Chief Scientific Officer	Direct	Sale	1,304	0.37	$482.48	202,385	4/A
2023-07-10	Lucchino, David L.	Director,Officer	President and CEO	Direct	Sale	2,591	0.38	$984.58	715,423	4/A
2023-07-06	Lucchino, David L.	Director,Officer	President and CEO	Direct	Sale	2,773	0.34	$942.82	720,648	4/A
2023-07-06	Mitrano, Richard J.	Officer	VP Finance & Operations	Direct	Sale	224	0.35	$78.40	55,771	4/A
2023-07-06	Loose, Christopher R.	Officer	Chief Scientific Officer	Direct	Sale	1,384	0.34	$470.56	198,666	4/A
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

108.22%

Inst. Shares: 12,552,266

Shares Outstanding: 11,598,717

2025-12-31

79.88%

Inst. Shares: 7,504,991

Shares Outstanding: 9,395,402

2025-09-30

103.39%

Inst. Shares: 9,710,054

Shares Outstanding: 9,391,559

2025-06-30

96.35%

Inst. Shares: 9,047,787

Shares Outstanding: 9,390,542

2025-03-31

103.30%

Inst. Shares: 9,693,860

Shares Outstanding: 9,384,266

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	12,552,266	11,598,717	108.22%
2025-12-31	7,504,991	9,395,402	79.88%
2025-09-30	9,710,054	9,391,559	103.39%
2025-06-30	9,047,787	9,390,542	96.35%
2025-03-31	9,693,860	9,384,266	103.30%
2024-12-31	9,427,747	8,920,561	105.69%
2024-09-30	8,483,042	9,303,218	91.18%
2024-06-30	8,344,342	8,986,545	92.85%
2024-03-31	6,858,714	8,019,626	85.52%
2023-12-31	6,130,731	1,529,321	-
2023-09-30	9,918,909	284,156	-
2023-06-30	4,187,614	276,482	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Korro Bio, Inc. (KRRO) — SEC Financial Statements & Analysis

Korro Bio, Inc. (KRRO) is a pharmaceutical preparations company, incorporated in DE. Korro Bio, Inc. trades on Nasdaq as: KRRO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Korro Bio, Inc. reported a -62.08% year-over-year revenue growth, a Debt-to-Equity ratio of 0.58x, a Price-to-Sales (P/S) ratio of 97.49x (TTM), a Price-to-Book (P/B) ratio of 2.25x (TTM), at a market cap of $232.21M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -62.08%
Debt To Equity: 0.58x
P/S TTM: 97.49x
P/B TTM: 2.25x
Market Cap: $232.21M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Korro Bio, Inc. in?

Korro Bio, Inc. (KRRO) operates in the Pharmaceutical Preparations industry.

What is KRRO's market cap?

Korro Bio, Inc. (KRRO) has a market capitalization of $232.21M as of 2026-06-30.

What exchange does KRRO trade on?

Korro Bio, Inc. (KRRO) trades on the Nasdaq.

Where is Korro Bio, Inc. incorporated?

Korro Bio, Inc. is incorporated in DE.

Korro Bio, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Korro Bio, Inc. (KRRO) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

Korro Bio, Inc. (KRRO) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.